The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry
碩士 === 國立臺北大學 === 企業管理學系 === 105 === The purpose of the study is to identify the relationship between patents and market value of pharmaceutical companies in the US by using the artificial neural network (ANN). The patent data are collected from U.S. Patent & Trademark Office (USPTO). The financ...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/gdank7 |
id |
ndltd-TW-105NTPU0121044 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-105NTPU01210442019-05-15T23:17:18Z http://ndltd.ncl.edu.tw/handle/gdank7 The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry 探討發明人數、平均專利年齡與專利熵指數對於公司市值之影響-以美國製藥業為例 CHEN,YEN-TING 陳姸廷 碩士 國立臺北大學 企業管理學系 105 The purpose of the study is to identify the relationship between patents and market value of pharmaceutical companies in the US by using the artificial neural network (ANN). The patent data are collected from U.S. Patent & Trademark Office (USPTO). The financial data are collected from the database of COMPUSTAT. The study finds that the number of inventors per company and entropy have positive effects on a pharmaceutical company's market value, while average age of patents has negative effects on a pharmaceutical company's market value. Therefore, company could enhance number of inventors and optimize average age of patents to increase market value. However, when a company’s entropy is at a high level, its market value will not be increasing without bound. For a long-term strategy, the company should consider a diversification strategy if it comes to the point. CHEN, YU-SHAN 陳宥杉 2017 學位論文 ; thesis 67 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立臺北大學 === 企業管理學系 === 105 === The purpose of the study is to identify the relationship between patents and market value of pharmaceutical companies in the US by using the artificial neural network (ANN). The patent data are collected from U.S. Patent & Trademark Office (USPTO). The financial data are collected from the database of COMPUSTAT. The study finds that the number of inventors per company and entropy have positive effects on a pharmaceutical company's market value, while average age of patents has negative effects on a pharmaceutical company's market value. Therefore, company could enhance number of inventors and optimize average age of patents to increase market value. However, when a company’s entropy is at a high level, its market value will not be increasing without bound. For a long-term strategy, the company should consider a diversification strategy if it comes to the point.
|
author2 |
CHEN, YU-SHAN |
author_facet |
CHEN, YU-SHAN CHEN,YEN-TING 陳姸廷 |
author |
CHEN,YEN-TING 陳姸廷 |
spellingShingle |
CHEN,YEN-TING 陳姸廷 The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry |
author_sort |
CHEN,YEN-TING |
title |
The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry |
title_short |
The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry |
title_full |
The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry |
title_fullStr |
The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry |
title_full_unstemmed |
The Influences of Number of Inventors, Average Age of Patents, and Entropy of Patents upon Market Value in the American Pharmaceutical Industry |
title_sort |
influences of number of inventors, average age of patents, and entropy of patents upon market value in the american pharmaceutical industry |
publishDate |
2017 |
url |
http://ndltd.ncl.edu.tw/handle/gdank7 |
work_keys_str_mv |
AT chenyenting theinfluencesofnumberofinventorsaverageageofpatentsandentropyofpatentsuponmarketvalueintheamericanpharmaceuticalindustry AT chényántíng theinfluencesofnumberofinventorsaverageageofpatentsandentropyofpatentsuponmarketvalueintheamericanpharmaceuticalindustry AT chenyenting tàntǎofāmíngrénshùpíngjūnzhuānlìniánlíngyǔzhuānlìshāngzhǐshùduìyúgōngsīshìzhízhīyǐngxiǎngyǐměiguózhìyàoyèwèilì AT chényántíng tàntǎofāmíngrénshùpíngjūnzhuānlìniánlíngyǔzhuānlìshāngzhǐshùduìyúgōngsīshìzhízhīyǐngxiǎngyǐměiguózhìyàoyèwèilì AT chenyenting influencesofnumberofinventorsaverageageofpatentsandentropyofpatentsuponmarketvalueintheamericanpharmaceuticalindustry AT chényántíng influencesofnumberofinventorsaverageageofpatentsandentropyofpatentsuponmarketvalueintheamericanpharmaceuticalindustry |
_version_ |
1719145238136619008 |